Close Menu

NEW YORK – Digital pathology firm Inspirata announced two deals Tuesday, one to market and distribute Mikroscan's digital pathology and telemicroscopy systems in the US, and one to partner with Augmentiqs to integrate its Dynamyx digital pathology workflow solution with augmented reality. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.


This webinar will discuss a study that set to assess the efficacy and safety of osimertinib in EGFR T790M positive non-small cell lung cancer (NSCLC) patients identified by using plasma sample and cobas EGFR Mutation test v2. This is the first prospective study to use liquid biopsy upfront to evaluate osimertinib efficacy.